Delivery Order SPE2DR25D3014-SPE2DR26FP1KP
- Not listed
- The Defense Logistics Agency awarded a $1,890.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on December 12, 2025, with an ultimate completion date of December 15, 2025. This non-set-aside award supports federal medical procurement needs, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Qulipta 60 mg tablets (30-count units) with a ceiling value of $1,117.98. This competitive, non-set-aside delivery order is structured as a firm fixed-price contract with an ultimate completion date of December 4, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) valued at $3,530.41 with a firm fixed price and no set-aside designation. The award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract. The order, valued at $2,400.59, represents a competitive award with no set-aside designation and a completion deadline of July 28, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,221.69 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Qulipta 30 mg tablets (30-count). The contract utilizes firm fixed-price pricing with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,547.07 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) under a firm fixed price contract with a ceiling value of $84,312.40. The order was competitively awarded without set-aside restrictions and is scheduled for completion by December 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) on November 20, 2025, with a ceiling value of $2,049.80 and an ultimate completion date of November 21, 2025. This firm fixed-price, non-set-aside contract is a child order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Qulipta 60 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,568.63. This non-set-aside competitive award is scheduled for completion by September 2, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,173.62 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to supply...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1KPDelivery Order
The Defense Logistics Agency awarded a $3,549.72 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) on December 19, 2025, with completion targeted for December 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains through competitively awarded orders ranging from small transactions to substantial procurements exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/18/25 |